Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

177.62 -4.06 (-2.23%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results ↗
Charles River Laboratories (NYSE: CRL) beat Q1 earnings estimates but lowered its FY2026 forecast. Analysts maintain positive outlook with raised price targets. 
Via Benzinga
News headline image
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.2% year on y... 
Via StockStory
Topics Artificial Intelligence
News headline image
Charles River (CRL) Q1 2026 Earnings Transcript ↗
Charles River (CRL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Charles River Laboratories (NYSE:CRL) Beats Q1 Estimates, Reaffirms Guidance ↗
Via Chartmill
News headline image
Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.2% year on ... 
Via StockStory
News headline image
Charles River Laboratories Announces First-Quarter 2026 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect
Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings this Thursday before market hours. Here’s what investors should know. C... 
Via StockStory
News headline image
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
From Charles River Laboratories
Via Business Wire
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such a... 
Via StockStory
News headline image
1 S&P 500 Stock to Own for Decades and 2 We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
Charles River Highlights Effectiveness of VCGs in Toxicology
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener... 
Via StockStory
Topics Economy
News headline image
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci... 
Via StockStory
Topics Government Stocks
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Monday. ↗
Via Chartmill
Monday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Economy Government Stocks
News headline image
1 Value Stock on Our Buy List and 2 We Turn Down
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
Movers and shakers in today's after-hours session for S&P500 stocks? ↗
Via Chartmill
Which stocks are moving after the closing bell on Monday? ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
3 Reasons CRL is Risky and 1 Stock to Buy Instead
Over the past six months, Charles River Laboratories has been a great trade, beating the S&P 500 by 7.5%. Its stock price has climbed to $168.91, representin... 
Via StockStory
Topics Stocks
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack
Via StockStory
News headline image
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Provides Update on Planned Divestitures
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.